Skip to main content

Research Repository

Advanced Search

Development of a multipurpose small animal phantom for pre-clinical radiotherapy studies

People Involved

Profile image of Dr Vicky Green

Dr Vicky Green V.L.Green@hull.ac.uk
Post-doctoral Research Scientist

Project Description

The project aims to both reduce the total number of animals used for preclinical radiotherapy experiments whilst concurrently increasing the accuracy of such investigations in order to maximise their clinical impact. This will be achieved through the development of a multipurpose small animal phantom and standardized dosimetry procedures aiming to reduce dose uncertainties in preclinical investigations (due to the steep dose responses, a 5% improvement in dose uncertainty would roughly halve the number of animal required to achieve the same statistical relevance). Inclusion of a bespoke microfluidic device, for human tissue culture, will also offer an alternative in vivo-like option for radiation-drug synergistic studies, standardizing radiobiological experiments to be undertaken by new groups using human tissue biopsies. The proposed phantom will scale down established medical physics methodologies to provide confidence and accuracy for pre-clinical studies to match current clinical practice. The project addresses pre-clinical issues identified by translational research groups, the funding bodies and the clinical community opening up new business opportunities for dosimetry services.

Status Project Complete
Value £193,197.00
Project Dates Apr 1, 2016 - Mar 31, 2019
Partner Organisations Xstrahl Ltd
National Physical Laboratory

You might also like

TRANSFORM: Reducing Inequalities in Cancer Outcomes in Yorkshire: Realising our potential for innovation in Diagnosis, Patient Management, Survivorship and Palliative Care Research Sep 1, 2017 - Dec 31, 2026
The death rate is higher in Yorkshire than the rest of England resulting in about 200 extra deaths each year of which more than half are in Hull. There are other significant cancer outcome inequalities between different groups; for example poorer pe... Read More about TRANSFORM: Reducing Inequalities in Cancer Outcomes in Yorkshire: Realising our potential for innovation in Diagnosis, Patient Management, Survivorship and Palliative Care Research.

The effect of corticosteroids on the release of immune modulating factors from Graves’ disease tissue maintained using microfluidic culture. Jun 1, 2017 - May 31, 2018
Graves’ disease (GD) affects approximately 2% of adult women. Current treatments for GD include anti-thyroid drugs, radioiodine therapy and surgery, of which none tackle the underlying pathogenic process. Immunosuppressive agents are therefore of gro... Read More about The effect of corticosteroids on the release of immune modulating factors from Graves’ disease tissue maintained using microfluidic culture..